These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
874 related articles for article (PubMed ID: 32421155)
1. Planning for a COVID-19 Vaccination Program. Schaffer DeRoo S; Pudalov NJ; Fu LY JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155 [No Abstract] [Full Text] [Related]
2. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust. Trogen B; Oshinsky D; Caplan A JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392 [No Abstract] [Full Text] [Related]
3. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. COCONEL Group Lancet Infect Dis; 2020 Jul; 20(7):769-770. PubMed ID: 32445713 [No Abstract] [Full Text] [Related]
4. Even covid-19 can't kill the anti-vaccination movement. Megget K BMJ; 2020 Jun; 369():m2184. PubMed ID: 32499217 [No Abstract] [Full Text] [Related]
5. Audio Interview: Guidelines for Covid-19 Vaccine Deployment. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696 [No Abstract] [Full Text] [Related]
6. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust. Schwartz JL N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716 [No Abstract] [Full Text] [Related]
7. Audio Interview: Covid-19 in Europe and New Information on Vaccines. Rubin EJ; Baden LR; Haug CJ; Morrissey S N Engl J Med; 2020 Nov; 383(21):e134. PubMed ID: 33207102 [No Abstract] [Full Text] [Related]
8. Preparing for the vaccine. Nat Biotechnol; 2020 Nov; 38(11):1219. PubMed ID: 33110209 [TBL] [Abstract][Full Text] [Related]
9. Ensuring Uptake of Vaccines against SARS-CoV-2. Mello MM; Silverman RD; Omer SB N Engl J Med; 2020 Oct; 383(14):1296-1299. PubMed ID: 32589371 [No Abstract] [Full Text] [Related]
11. Keeping track of the SARS-CoV-2 vaccine pipeline. Parker EPK; Shrotri M; Kampmann B Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290 [TBL] [Abstract][Full Text] [Related]
12. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2. Plotkin SA J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616 [TBL] [Abstract][Full Text] [Related]
13. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. Wang EA; Zenilman J; Brinkley-Rubinstein L JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972 [No Abstract] [Full Text] [Related]
14. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts. Mahase E BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065 [No Abstract] [Full Text] [Related]
15. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Coish JM; MacNeil AJ Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062 [TBL] [Abstract][Full Text] [Related]
16. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency. Avorn J; Kesselheim A JAMA; 2020 Oct; 324(13):1284-1285. PubMed ID: 32870268 [No Abstract] [Full Text] [Related]
17. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2? McPartlin SO; Morrison J; Rohrig A; Weijer C BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564 [No Abstract] [Full Text] [Related]
18. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby. Fujiwara K; Quinn MA Int J Gynecol Cancer; 2020 Aug; 30(8):1255. PubMed ID: 32624498 [No Abstract] [Full Text] [Related]